GlassScriptPhysician profile
Jonathan Lewis Witten
NPI 1851617732
$8,782.79
in general payments reported to CMS, 2019-2025
36 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $550 · 2021: $1,774 · 2022: $2,003 · 2023: $745 · 2024: $1,670 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,100 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,099.69 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,756.67 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $923.99 | 2019-2025 | Ams 700, Lithovue |
| Coloplast Corp | $723.07 | 2021-2022 | |
| Teleflex LLC | $439.32 | 2023-2024 | Urolift |
| Cumberland Pharmaceuticals, INC. | $348.17 | 2022 | |
| Blue Earth Diagnostics | $291.62 | 2019-2021 | |
| Urogen Pharma, INC. | $264.46 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $250.90 | 2022-2024 | Prolaris |
| Sanara Medtech INC. | $250.11 | 2022-2025 | Celleraterx |
| Medtronic USA, INC. | $249.03 | 2020 | |
| Procept Biorobotics Corporation | $223.21 | 2023-2025 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $215.14 | 2020-2024 | Xiaflex |
| Palette Life Sciences, INC. | $173.25 | 2022 | |
| Accord Healthcare, INC. | $160.02 | 2022-2025 | |
| Axonics, INC. | $151.07 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $150.60 | 2021-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $150.22 | 2025 | Adstiladrin |
| Stryker Corporation | $143.54 | 2024 | 1788 |
| Neotract INC. | $129.03 | 2020 | |
| Sumitomo Pharma America, INC. | $127.84 | 2023-2025 | Orgovyx, Gemtesa |
| Calyxo, INC. | $97.92 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $75.55 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| C. R. Bard, INC. & Subsidiaries | $71.21 | 2020 | |
| Verity Pharmaceuticals INC. | $69.34 | 2024-2025 | Trelstar, Tlando |
| Novartis Pharmaceuticals Corporation | $64.29 | 2025 | |
| Endo USA, INC. | $56.82 | 2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $50.14 | 2020-2024 | Myrbetriq, Xtandi |
| Tolmar, INC. | $40.15 | 2023-2024 | |
| Myovant Sciences INC. | $31.52 | 2022 | |
| Bioprotect Medical, INC. | $22.84 | 2024 | Bioprotect Balloon Implant System |
| Pfizer INC. | $16.85 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.91 | 2020 | |
| Travere Therapeutics, INC. | $13.90 | 2021 | |
| Karl Storz Endoscopy-America | $12.99 | 2023 | Hopkins |
| Baxter Healthcare | $11.77 | 2020 | |
| Antares Pharma, INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Witten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.